Get started
Author

T. Zachary Gunter

Observed name: Thomas Z. Gunter
OpenAlex ID: A5077567477
Feasibility of mini-tablets as a flexible drug delivery tool
2017 · Biplob Mitra, Jessica Chang, et al. · International Journal of Pharmaceutics · 57
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
2016 · Haiyan Wang, Shanbao Cai, et al. · Journal of neurosurgery · 49
PDF
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2015 · Eva Tonsing-Carter, Barbara J. Bailey, et al. · Molecular Cancer Therapeutics · 42
A Novel Sample Selection Strategy by Near-Infrared Spectroscopy-Based High throughput Tablet Tester for Content Uniformity in Early-Phase Pharmaceutical Product Development
2012 · Zhenqi Shi, James G. Hermiller, et al. · Journal of Pharmaceutical Sciences · 12
An Asymmetric Synthesis of a Chiral Sulfone Acid with Concomitant Hydrolysis and Oxidation to Enable the Preparation of a Glucokinase Activator
2012 · Amy C. DeBaillie, Nicholas A. Magnus, et al. · Organic Process Research & Development · 11
Supplemental Figure S2 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S5 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S3 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S4 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S6 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S7 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S1 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Table S1, Supplemental Material and Methods and Supplemental Figure Legends from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Table S1, Supplemental Material and Methods and Supplemental Figure Legends from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S5 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S2 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S4 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S1 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S6 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S7 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S3 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Data from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Data from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
2017 · Haiyan Wang, Shanbao Cai, et al. · PMC
Abstract 2741: Sensitization of temozolomide-mediated glioblastoma cell death by targeting MDM2: Assessment of PD biomarkers, brain penetration, and efficacy in humanized orthotopic xenograft models
2014 · Haiyan Wang, Shanbao Cai, et al. · Cancer Research
Works count: 25
Citation count: 171
H-index: 5
I10-index: 5
Year
Topic
Type